Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| Dir | Wang Xiaodong | 4.58M | $1.56B | - |
| Pres | Wang Lai | 1.45M | $495.36M | - |
| Dir | BAKER BROS. ADVISORS LP | 148.1K | $50.53M | - |
| Dir | HOOPER ANTHONY C | 64.7K | $22.10M | - |
| Dir | Riva Alessandro | 56.9K | $19.43M | - |
Transactions
7 filings · page 12
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2021-11-08 | Wang Xiaodong | - | Sell | 2,015 | $347.50 | $700,216.97 | -13.1% | → |
| 2021-11-08 | Wang Xiaodong | - | Sell | 3,300 | $351.76 | $1,160,812.03 | -18.4% | → |
| 2021-11-08 | Wu Xiaobin | President, COO & GM China | Sell | 4,853 | $358.96 | $1,742,047.80 | -43.0% | → |
| 2021-10-19 | Huang Jane | CMO, Hematology | Sale+OE | 1,500 | $372.78 | $559,163.00 | -24.2% | → |
| 2021-09-24 | BeiGene, Ltd. | - | Buy | 2,543,800 | $2.85 | $7,249,830.00 | +52.9% | → |
| 2021-09-20 | Huang Jane | CMO, Hematology | Sale+OE | 6,000 | $397.96 | $2,387,773.97 | -15.6% | → |
| 2021-09-15 | OYLER JOHN | Chief Executive Officer | Sell | 216,461 | $71.49 | $15,475,616.14 | -10.5% | → |